a b s t r a c t
In the clinical setting, repeated exposures (10-30) to low-doses of ionizing radiation (6200 cGy), as seen in radiotherapy for cancer, causes fatigue. Almost nothing is known, however, about the fatigue inducing effects of a single exposure to environmental low-dose ionizing radiation that might occur during highaltitude commercial air flight, a nuclear reactor accident or a solar particle event (SPE). To investigate the short-term impact of low-dose ionizing radiation on mouse biobehaviors and neuroimmunity, male CD-1 mice were whole body irradiated with 50 cGy or 200 cGy of gamma or proton radiation. Gamma radiation was found to reduce spontaneous locomotor activity by 35% and 36%, respectively, 6 h post irradiation. In contrast, the motivated behavior of social exploration was un-impacted by gamma radiation. Examination of pro-inflammatory cytokine gene transcripts in the brain demonstrated that gamma radiation increased hippocampal TNF-a expression as early as 4 h post-irradiation. This was coupled to subsequent increases in IL-1RA (8 and 12 h post irradiation) in the cortex and hippocampus and reductions in activity-regulated cytoskeleton-associated protein (Arc) (24 h post irradiation) in the cortex. Finally, restraint stress was a significant modulator of the neuroimmune response to radiation blocking the ability of 200 cGy gamma radiation from impairing locomotor activity and altering the brain-based inflammatory response to irradiation. Taken together, these findings indicate that low-dose ionizing radiation rapidly activates the neuroimmune system potentially causing early onset fatigue-like symptoms in mice.
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Introduction
The impact of ionizing radiation on behavior and neuroimmunity is an emerging field. Currently, the primary focus is on clinically delivered radiation therapy to oncology patients and the consequent adverse biobehavioral impact these critical treatments engender (Bower et al., 2009; Hofman et al., 2007; James, 2006) . Therapeutic radiation involves delivery of relatively high doses (30-80 Gy/14-60 days) administered focally and strategically to limit treatment of uninvolved normal tissues (Lawrence et al., 2008) . The majority of patients receiving radiotherapy over the past century have been treated with electrons, X-rays (high energy photons) or gamma-rays (high energy photons). The distinction between X-and gamma-rays from a radiotherapy perspective relates to the source of the photons: X-rays originate from outer electrons and gamma rays originate from atomic nuclei. In radiotherapy applications, however, both X-and gamma-rays are photons in the 1-20 MeV energy range. The physical properties of these forms of radiation cause maximal energy deposition (dose) to occur early in the tissue particle track at depths of 0.5-4 cm. Recently, there has been renewed interest in treating patients with heavier charged particles such as protons, which deposit the majority of their dose toward the end of the tissue particle track at depths up to 20-30 cm. This affords more focused delivery of dose to deeply seated neoplasms with less radiation being administered to tissues more distal to the target (Evaluation Subcommittee of ASTRO's Emerging Technologies Committee, 2009 ). In addition to the differences in macroscopic dose distribution, photons and protons create disparate microscopic dose distributions due to dissimilar linear energy transfer (LET) coefficients. Importantly, differences in microdosimetric track structure may cause photons and protons to have qualitatively and quantitatively unequal dose-toxicity profiles (Cengel et al., 2010) .
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